Evaluating diversity, equity, and inclusion consultation requests
Aileen I. Fernandez(Yale University), Terika McCall(Yale University), Antentor Hinton(Vanderbilt University), Christina M. Termini(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Brionna Davis-Reyes(Yale University), C.A. Starbird(University of North Carolina Health Care)
Cited by 1
Related Papers
Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue
|JAMA Oncology|2022|347
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer
|Modern Pathology|2021|166
Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer
|Laboratory Investigation|2022|141
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry
|Modern Pathology|2023|98